^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
denintuzumab mafodotin (SGN-CD19A)
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Pfizer
Drug class:
Microtubule inhibitor, CD19-targeted antibody-drug conjugate
Related drugs:
